title: Inactivation studies of acetylcholinesterase with phenylmethylsulfonyl fluoride.
abstract: Acetylcholinesterase (AChE), a serine hydrolase, is potentially susceptible to inactivation by phenylmethylsulfonyl fluoride (PMSF) and benzenesulfonyl fluoride (BSF). Although BSF inhibits both mouse and Torpedo californica AChE, PMSF does not react measurably with the T. californica enzyme. To understand the residue changes responsible for the change in reactivity, we studied the inactivation of wild-type T. californica and mouse AChE and mutants of both by BSF and PMSF both in the presence and absence of substrate. The enzymes investigated were wild-type mouse AChE, wild-type T. californica AChE, wild-type mouse butyrylcholinesterase, mouse Y330F, Y330A, F288L, and F290I, and the double mutant T. californica F288L/F290V (all mutants given T. californica numbering). Inactivation rate constants for T. californica AChE confirmed previous reports that this enzyme is not inactivated by PMSF. Wild-type mouse AChE and mouse mutants Y330F and Y330A all had similar inactivation rate constants with PMSF, implying that the difference between mouse and T. californica AChE at position 330 is not responsible for their differing PMSF sensitivities. In addition, butyrylcholinesterase and mouse AChE mutants F288L and F290I had increased rate constants ( approximately 14 fold) over those of wild-type mouse AChE, indicating that these residues may be responsible for the increased sensitivity to inactivation by PMSF of butyrylcholinesterase. The double mutant T. californica AChE F288L/F290V had a rate constant nearly identical with the rate constant for the F288L and F290I mouse mutant AChEs, representing an increase of approximately 4000-fold over the T. californica wild-type enzyme. It remains unclear why these two positions have more importance for T. californica AChE than for mouse AChE.
authors.affiliation: Department of Chemistry, Swarthmore College, Swarthmore, PA 19081, USA.
authors.forename: D
authors.initials: D
authors.lastname: Kraut
authors.forename: H
authors.initials: H
authors.lastname: Goff
authors.forename: R K
authors.initials: RK
authors.lastname: Pai
authors.forename: N A
authors.initials: NA
authors.lastname: Hosea
authors.forename: I
authors.initials: I
authors.lastname: Silman
authors.forename: J L
authors.initials: JL
authors.lastname: Sussman
authors.forename: P
authors.initials: P
authors.lastname: Taylor
authors.forename: J G
authors.initials: JG
authors.lastname: Voet
mesh_terms: D000110:Acetylcholinesterase / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004524:Eels; D005464:Fluorobenzenes / Q000494:pharmacology; D051379:Mice; D008958:Models, Molecular; D010664:Phenylmethylsulfonyl Fluoride / Q000494:pharmacology*; D013379:Substrate Specificity; D013450:Sulfones / Q000494:pharmacology
chemical_list: D002800:Cholinesterase Inhibitors; D005464:Fluorobenzenes; D013450:Sulfones; C050355:4-fluorobenzenesulfonyl fluoride; D010664:Phenylmethylsulfonyl Fluoride; D000110:Acetylcholinesterase